Top drug regulator Richard Pazdur filed papers to retire from the Food and Drug Administration at the end of this month, but ...

The US Food and Drug Administration’s longtime oncology chief has filed to retire from the agency just weeks after he was ...

Longtime FDA oncology leader and newly appointed Center for Drug Evaluation and Research director Richard Pazdur has filed ...

Weeks after being named head of CDER, Pazdur has submitted paperwork to step down at the end of the month, exacerbating ...

Richard Pazdur, the US Food and Drug Administration’s lead drug regulator, plans to retire from the agency only weeks after ...

Dec 2 (Reuters) - The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard ...

Richard Pazdur had clashed with Trump officials on the legality and pace of their initiatives. He could still withdraw his resignation, but it is unlikely, one person said.

Long-serving FDA figure Richard Pazdur has filed papers to retire, shortly after being appointed to lead the agency's Center ...

Mere weeks after being named the nation’s top drug regulator, Richard Pazdur, M.D., is taking steps to retire as head of the FDA’s Center for Drug Evaluation and Research at the end of this month, | ...

Richard Pazdur, the new director of the Center for Drug Evaluation and Research, raised concerns amid the rollout of several ...

The U.S. Food and Drug Administration's newly appointed head of the drug evaluation department, Richard Pazdur, is set to ...